Sign Up for an Offer You Can't Refuse
We are a TechBio company offering a unique opportunity for companies to work with us to experience the difference our platform can make in a research and development pipeline. NemaLife's technology unclogs the typical bottlenecks of ingredient discovery and product development.
View the full terms and conditions of this promotion.
Now through February 9th, we want to offer those in the industry the opportunity to work with us to address their research and development needs . For our Probiota promotion, we will be choosing 5 companies to try our platform at no cost to them.* To qualify, sign up within the allotted time frame so we can learn more about how we can help you innovate!
​
Why You Want to Sign Up
Evaluating novel ingredients in mammals takes years and can cost millions slowing down product development.
​
We're here to change that.
Cost Savings
Using mammals for testing costs at least 10x more than using nematodes with our patented microfluidic chip. Yes, worms work.
Product Timeline Acceleration
We bring products to market 10x faster than traditional methods of research and development. Time is money.
Evolving AI Innovations
Our engineers are innovative, always evolving platforms for us and our partners. Visionaries are never stagnant.
Cruelty-Free
Consumers appreciate when we reduce testing on mammals for products they care about.
Sign Up Now!
Sign up for an opportunity to test your product on our platform!
Have questions?
Reach out to us!
Terms & Conditions of Offer
Interested companies must sign up between January 31, 2023, and February 9, 2023, to qualify and be considered. *This offer is valid for evaluating one test ingredient, a positive control, and one no-treatment control for healthy aging or obesity on NemaLife's organism-on-chip platform. Additional services can be utilized but are not included in this offer and may come at an additional charge. Applicants must be 18 years of age or older. You agree to our site's terms by submitting this form. Participants will be reviewed and chosen by our scientific team's assessment of applicants' research and development goals. Participants will be contacted no later than 03/01/2023. Companies not chosen may qualify for limited introductory pricing.
​